Kim B. Nemirow


  • JD, cum laude, Northwestern University School of Law, 2003
  • BA (Public Policy), Brown University, 1997


  • District of Columbia, 2010
  • Massachusetts, 2006
  • New York, 2004
  • Hong Kong, Registered Foreign Lawyer
  • Honorable Faith S. Hochberg, U.S. District Court for the District of New Jersey (2004 - 2005)

In 2013, Kim founded the Hong Kong chapter of the Women’s White Collar Defense Association, a global coalition of women attorneys and other professionals with relevant expertise who specialize in white collar criminal defense. She also spearheaded the Ropes & Gray Women’s Forum initiative for the firm’s offices in Asia (Hong Kong, Shanghai, Tokyo and Seoul) to build a mentoring community for women in the workplace.

For several years, Kim served as one of the firm's coordinators of the Discovering Justice program in which middle school students learn about the justice system while preparing a mock trial.

Prior to law school, Kim taught elementary school in the South Bronx, New York as a Teach For America corps member and taught for a year in Guatemala.

  • Legal 500 Asia-Pacific: Leading Individual in Regulatory: Anti-Corruption/Compliance (2016)
  • Chambers Global: The World's Leading Lawyers for Business (2015)
  • Chambers Asia 2015: Up & Coming (2015)
  • Global Investigations Review “40 under 40” (2014)
  • Financial Times US Innovative Lawyers Report 2013 - Recognized Ropes & Gray’s web-based econometric Risk Matrix tool, developed by the firm’s anti-corruption and international risk team, as a “standout” product
  • Euromoney LMG Women in Business Law -"Rising Star" (2013)

Kim B. Nemirow


View the Chinese version.

Kim is a partner of Ropes & Gray LLP and a Registered Foreign Lawyer in the Hong Kong office. She devotes her practice to white collar matters in Asia. She has extensive experience advising multinational organizations and individuals in a wide variety of U.S. DOJ and SEC investigations, internal investigations, and compliance matters. In addition to her experience as a government enforcement attorney in the U.S. handling matters involving potential violations of the FCPA, securities laws, and various health care fraud statutes, Kim has led many investigations in China for private equity, pharmaceutical, medical device, and other China-based clients and has particular expertise managing the challenges facing companies doing business in China. Kim is also regularly called upon by clients to advise regarding anti-corruption risk assessments and due diligence in China, and to conduct trainings of personnel in China.


  • Advised Blackstone in its joint venture with China Vanke, China’s largest residential developer, this was the first transaction to receive clearance from the PRC Ministry of Commerce under the simplified merger filing procedure. Named “Real Estate & Construction Deal of the Year” for 2015 by China Law and Practice.
  • Advised Blackstone in the acquisition of Hindustan Construction’s stake in 247 Park, a large commercial property in the transit hub of Vikhroli, a suburb of Mumbai. Named “Deal of the Year” for 2015 by the India Business Law Journal.
  • Representing multiple multinational pharmaceutical and medical device companies in anti-corruption investigations in China.
  • Represented a global financial institution in an industry-wide FCPA investigation focusing on interactions with Sovereign Wealth Funds.
  • Conducted numerous anti-corruption internal investigations in Asia for large multinational companies, including matters throughout China, Malaysia, and Indonesia. 
  • Conducted an internal investigation on behalf of a global investment bank into hiring issues in China.
  • Led extensive anti-corruption and anti-money laundering due diligence in connection with private equity and other investments in high risk countries around the world, including in China, India, Brazil, and Russia.
  • Led anti-corruption risk assessments for more than 100 private equity portfolio companies around the world, including companies in China, India, Central and South America, Europe, and Africa.
  • Developed and implemented anti-corruption compliance programs for several private equity firms and their global portfolio companies.
  • Represented multiple major medical device manufacturers in federal criminal investigations into the companies’ marketing practices and relationships with physicians.
  • Achieved a dismissal of a False Claims Act action alleging improper marketing practices against a multinational medical device manufacturer.
  • Represented a major pharmaceutical company in several multi-defendant consumer protection actions brought by states’ attorneys general regarding Medicaid pricing fraud.



  • Panelist, “Crisis Communication: Handling Communications as Part of a Litigation Strategy ,”FTI Consulting and Ropes & Gray Roundtable, New York (November 2015)
  • Presenter, “Effective Monitoring and Risk Assessment,” Joint AdvaMed and APACMed Compliance Meeting, Singapore (July 2015)
  • Panelist, “How to Update and Localise your Global Anti-Corruption Programme to Protect Against the Unique Pitfalls and Risks of Operating in China,” at C5’s 3rd Annual Australian Anti-Corruption, Compliance & risk Management Summit (May 2015)
  • Presenter, “Focus on China’s Commercial Bribery Crackdown,” American Conference Institute’s 3rd Asia-Pacific Summit on Anti-Corruption, Compliance and Risk Management, Singapore (December 2014)
  • Presenter, “Developments in International Anti-Corruption Law — Recent Enforcement Trends and Common Risk Areas in Asia,” Ropes & Gray Teleconference Briefing, Tokyo (September 2014)
  • Presenter, “Lessons Learned Conducting Investigations in China,” Ropes & Gray Government Enforcement Roundtable, Hong Kong (September 2014)
  • Presenter, “U.S. Antitrust & Anti-Corruption Enforcement,” Ropes & Gray Seminar co-hosted with The Japanese Institute of International Business Law, Tokyo (June 2014)
  • Moderator, “The 2014 Anti-corruption Environment: What it Means for Doing Business in China,” Chambers and Partners General Counsel Seminar in association with Ropes & Gray, Hong Kong (February 2014)
  • Presenter, “Distributor Management: Anti-corruption Risks and Best Practices,” Ropes & Gray Medical Device Roundtable: Distributor Management and Medical Device Tendering (July 2013)
  • Panelist, “How to Establish an Effective Third Party Monitoring Program,” American Conference Institute’s 6th China Summit on Anti-Corruption (June 2013)
  • Presenter, “Navigating the FCPA “Resource Guide”: Enforcement Trends and Compliance Tips,” Ropes & Gray webinar (November 2012)